Friday, 03 Apr 2020

TNF inhibitor

Datesort ascending Type Title Save
31 Aug 2016 News Another Biosimilar Approval - Etanercep-szzs by Novartis
30 Aug 2016 Social Drug retention rates are same between elderly and younger RA pts on TNFi. D/C for AE in old and efficacy in young.
29 Aug 2016 Slide of the day Non-Tuberculous Mycobacterial Infection are Common with TNF Inhibitors
18 Aug 2016 News Remicade Patent Infringements Denied: Opens Door for New Biosimilars
09 Aug 2016 News Etanercept May Lower Alzheimers Risk in Rheumatoid Arthritis
08 Aug 2016 Slide of the day Tuberculosis Risk Reduction Measures
27 Jul 2016 News Long-Term Safety of Adalimumab Reviewed
14 Jul 2016 News Sandoz Etanercept Biosimilar Voted for Approval by FDA Arthritis Advisory Committee
13 Jul 2016 News FDA Arthritis Advisory Committee Recommends Approval of Adalimumab Biosimilar
01 Jul 2016 News Adalimumab Approved for Uveitis
28 Jun 2016 News Cancer Risk Lower with TNF inhibitors in Rheumatoid Arthritis
27 Jun 2016 Social Humira sales projected to increase in next 3 years; others may decline
15 Jun 2016 Social FDA Arthritis Advisory to review Amgens ABP501 (ADA biosimilar) on 7/12 & 7/13 review Sandoz GP2015 (biosimilar ETN)
09 Jun 2016 Social Do all TNFi work the same way? J Exp Med article suggests unique Humira MOA, expanding functional Foxp3+ Treg cells
31 May 2016 Social Recurrent acute anterior uveitis responds to golimumab 50 mg qmo; 12/15 eyes from B27+ AS pts going into remission
31 May 2016 Social Samsung Bioepis Flixabi (a Remicade biosimilar) approved for all 6 indications in 28 EU states & Norway, Iceland.
26 May 2016 Social TNF inhibitors & Traveling? 1 infusion or injection OK a Wk early or late 2 Forget the dry ice, keep syringe cool n dry (eg purse) on plane
10 May 2016 Social Cimzia successfully given to RA & SpA thru pregnancy w/ undetectable CMZ in cord blood;but 3/13 3rd trimester infxns
02 May 2016 Blog Why Not Just Kick the TNFi Habit?
30 Apr 2016 Social Metanalysis: TNFi assoc w/ increase risk of perioperative infx (SSI): BUT risk decreases >38% w/ temporary cessation